Combination of Irinotecan, Oxaliplatin and 5-Fluorouracil as a Rechallenge Regimen for Heavily Pretreated Metastatic Colorectal Cancer Patients.

@article{Fernandes2017CombinationOI,
  title={Combination of Irinotecan, Oxaliplatin and 5-Fluorouracil as a Rechallenge Regimen for Heavily Pretreated Metastatic Colorectal Cancer Patients.},
  author={Gustavo Spadaccia dos Santos Fernandes and Maria Ignez F. Braghiroli and Michelle Artioli and Ana Carolina Carvalho Rocha Paterlini and Marcela Crosara Teixeira and Brenda Pires Gumz and Daniel da Motta Girardi and Oddone F M Braghiroli and Frederico Perego Costa and Paulo Marcelo Gehm Hoff},
  journal={Journal of gastrointestinal cancer},
  year={2017}
}
PURPOSE Our objective was to evaluate the benefit of re-exposing patients with refractory metastatic colorectal cancer (mCRC) to a combination of oxaliplatin, irinotecan and 5-fluorouracil treatment. METHODS We retrospectively analysed patients with mCRC who received a combination of oxaliplatin, irinotecan and fluorouracil as a rechallenge regimen after… CONTINUE READING